Single Source Procurement: Purchase of an Architect i1000 Analyzer

The Bloodborne Viruses Laboratory serves as the New York State public health reference laboratory and plays a critical role in the State's response to public health emergency, and prevention of the spread of disease. It is imperative that the program adhere to NYS laboratory guidelines and the national recommendations for rapid testing and diagnosis of infection. In order to maintain compliance, the lab is faced with the on-going challenge of the development of assays required for rapid detection of infections. This is achieved through the deployment of assays proven to be effective in early detection, and utilizing new technology to ensure the most rapid and effective testing methods are being utilized within the program.

A critical role for the program is maintaining the earliest possible detection of primary HIV-1 infection. Early detection is critical in reducing the possibility of an infected person remaining undiagnosed and unknowingly exposing others to HIV infection, ultimately spreading HIV disease within the State of New York. This detection method is also imperative for pediatric testing of babies born to HIV infected mothers.

Abbott Laboratories ARCHITECT HIV Ag/Ab Combo assay is one of only two FDA approved 4th generation HIV-1/2 Ag/Ab combo assays instruments recommended for laboratory based HIV antigen/antibody immunoassays for the detection and diagnosis of early marker HIV infection (HIV-1 p24 antigen), as well as antibodies to HIV-1 and HIV-2.

In support of the above mandate, the DOH received a one-time contract reporter exemption request (CRER) to procure an Architect i1000 Analyzer from Abbott Laboratories for the outlined testing purposes.

Procurement / Program Name	Bloodborne Viruses Laboratory
Contractor Name(s)	Abbott Laboratories
Contract Period	N/A
Contract Number(s)	WC517622